• $18.5M
    Market Cap
  • -29.69%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
2.0M
-82.35%
11.2M
+492.80%
-2.9M
-670.16%
500,000
-96.90%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
2.0M
-82.35%
11.2M
+492.80%
-2.9M
-670.16%
500,000
-96.90%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-8.6M
+16.76%
-7.4M
-27.75%
-10.2M
+18.91%
-8.6M
+11.63%
Depreciation and Amortization Expense
60,782
+47.87%
41,106
+43.42%
28,661
+203.19%
9,453
+2,387.63%
Total Operating Expenses
12.3M
-0.04%
12.4M
-18.08%
15.1M
+19.50%
12.6M
-2.89%
Operating Profit
-10.4M
+797.93%
-1.2M
-93.56%
-17.9M
+47.95%
-12.1M
-485.29%
Interest Income
744,074
-35.12%
1.1M
-16.10%
1.4M
+138.73%
572,578
+745.76%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-27,098
-86.67%
Interest Income and Expense and Net
744,074
-35.12%
1.1M
-16.10%
1.4M
+150.59%
545,480
+502.30%
Total Nonoperating Income and Expense
744,074
-36.08%
1.2M
-26.31%
1.6M
+16.03%
1.4M
+136.02%
Income before Taxes
-9.6M
-106,679.26%
9,033
+100.06%
-16.4M
+51.99%
-10.8M
+1,596.31%
Income Taxes
200
-70.63%
681
-9.80%
755
+10.87%
681
+240.50%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-9.6M
-115,428.04%
8,352
+100.05%
-16.4M
+51.99%
-10.8M
+1,595.88%
Net Income from Continuing Operations Applicable to Common
-9.6M
-115,369.46%
8,352
+100.05%
-16.4M
+52.00%
-10.8M
+1,596.31%
Basic EPS and Net Income
-1.77
N/A
N/A
N/A
-3.10
+2,483.33%
-0.12
+1,100.00%
Diluted EPS and Net Income
-1.69
N/A
N/A
N/A
-3.14
+2,315.38%
-0.13
+1,200.00%
Basic Weighted Average Shares
5.4M
+2.06%
5.3M
+1.31%
5.3M
-94.04%
88.5M
+1.75%
Diluted Weighted Average Shares
5.7M
+5.27%
5.4M
+2.90%
5.3M
-94.07%
88.9M
+2.23%
Balance Sheet
Cash and Cash Equivalents
5.2M
-16.11%
6.2M
+30.06%
4.8M
+51.56%
3.1M
+6.71%
Short-Term Investments
9.7M
-36.97%
15.4M
-10.64%
17.3M
-41.24%
29.4M
-29.49%
Cash and Cash Equivalents and Short-Term Investments
14.9M
-30.98%
21.6M
-1.83%
22.0M
-32.26%
32.5M
-27.09%
Total Current Assets
16.9M
-24.39%
22.3M
-2.36%
22.9M
-33.03%
34.1M
-26.40%
Accumulated Depreciation
1.3M
+4.97%
1.2M
+3.48%
1.2M
+2.48%
1.2M
+0.83%
Property and Plant and Equipment and Net
104,293
-36.82%
165,075
+42.19%
116,095
-11.77%
131,589
+1,724.84%
Total Long-Term Assets
23,753
0.00%
23,753
0.00%
23,753
0.00%
23,753
0.00%
Total Assets
17.0M
-24.45%
22.5M
-2.13%
23.0M
-38.73%
37.5M
-28.47%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.5M
+67.11%
1.5M
-42.51%
2.6M
+56.82%
1.7M
-70.12%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
17,166
-92.53%
229,856
-71.12%
Total Liabilities
2.5M
+67.11%
1.5M
-42.51%
2.6M
+37.93%
1.9M
-72.40%
Retained Earnings
-209.4M
+4.82%
-199.8M
-0.004%
-199.8M
+8.91%
-183.4M
+6.23%
Total Stockholders Equity
14.5M
-31.05%
21.0M
+3.08%
20.4M
-42.84%
35.6M
-21.80%
Total Shares Outstanding
6.2M
+15.16%
5.3M
+0.60%
5.3M
-93.99%
88.5M
+0.25%
Cash Flow
Cash from Operating Activities
-9.8M
+699.25%
-1.2M
-89.71%
-11.9M
-0.86%
-12.0M
+171.32%
Capital Expenditures
N/A
N/A
90,086
+584.18%
13,167
-90.16%
133,831
+1,663.02%
Cash from Investing Activities
5.9M
+140.84%
2.4M
-81.31%
13.1M
-8.46%
14.3M
+132.65%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.9M
+1,270.76%
209,340
-48.26%
404,567
+119.02%
-2.1M
-107.90%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-524.69%
+4,986.89%
-10.31%
-101.64%
628.98%
+125.95%
-2,423.87%
-12,537.85%
Return on Assets
-48.75%
-132,935.69%
0.04%
+100.07%
-54.02%
+126.00%
-23.90%
+1,366.25%
Return on Equity
-54.30%
-134,516.34%
0.04%
+100.07%
-58.40%
+120.38%
-26.50%
+1,172.08%
Revenue Growth
-82.35%
-116.71%
492.80%
+173.53%
-670.16%
+591.59%
-96.90%
N/A
Current Ratio
6.68
-54.75%
14.75
+69.84%
8.69
-57.29%
20.34
+146.33%
Cash Ratio
2.06
-49.80%
4.10
+126.22%
1.81
-3.36%
1.88
+257.17%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow